Pyxus International (PYYX) logs record 2026 Adjusted EBITDA and strong Q4 rebound
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Pyxus International reported strong fourth-quarter and solid full-year 2026 results, highlighted by record profitability and improved leverage. Q4 sales rose 35.2% year-over-year to $678.2 million, driven by higher leaf sales volumes from Africa and North America, lifting gross profit to $94.4 million and operating income to $43.7 million.
For the year ended March 31, 2026, sales slipped 2.8% to $2.413 billion as lower average pricing offset volume gains, but gross profit improved to $347.7 million and operating income increased to $162.7 million. Net income attributable to Pyxus was $14.6 million, or $0.56 per diluted share, and adjusted EBITDA reached a record $226.7 million.
Liquidity and balance sheet metrics strengthened: Q4 operating cash flow was $310.1 million, adjusted free cash flow was $352.1 million, cash and cash equivalents increased to $134.3 million, and net debt/adjusted EBITDA improved to 3.52x. For fiscal 2027, the company guides to $2.3–$2.5 billion of sales and $210–$240 million of adjusted EBITDA.
Positive
- None.
Negative
- None.
Insights
Pyxus delivers record profitability, strong cash flow, and modestly lower EBITDA guidance.
Pyxus International turned a strong finish to fiscal 2026 into record full-year Adjusted EBITDA of $226.7 million. Q4 sales grew 35.2% to $678.2 million, lifting gross margin to 13.9% and quarterly operating income to $43.7 million, reflecting higher leaf volumes and better mix.
Full-year sales declined 2.8% to $2.413 billion as average price per kilo fell 3.8%, but cost discipline and mix improvements supported higher operating income. Non-GAAP metrics show improving leverage: net debt was $798.6 million, with net debt/Adjusted EBITDA reduced to 3.52x and interest coverage rising to 1.63x.
Cash generation was a clear highlight, with Q4 operating cash flow of $310.1 million and Adjusted Free Cash Flow of $352.1 million, helped by collections on securitized receivables. Fiscal 2027 guidance calls for sales of $2.3–$2.5 billion and Adjusted EBITDA of $210–$240 million, suggesting stable performance after a record year in a global tobacco oversupply environment.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Q4 2026 sales: $678.2 million
Full-year 2026 sales: $2.413 billion
Full-year 2026 operating income: $162.7 million
+5 more
8 metrics
Q4 2026 sales
$678.2 million
Three months ended March 31, 2026; up 35.2% year-over-year
Full-year 2026 sales
$2.413 billion
Year ended March 31, 2026; down 2.8% vs 2025
Full-year 2026 operating income
$162.7 million
Year ended March 31, 2026; up from $153.3 million in 2025
Net income attributable to Pyxus 2026
$14.6 million
Year ended March 31, 2026; EPS $0.56 basic and diluted
Adjusted EBITDA 2026
$226.7 million
Record full-year Adjusted EBITDA for fiscal 2026
Net debt / Adjusted EBITDA
3.52x
As of March 31, 2026; improved from 3.70x in 2025
Q4 2026 operating cash flow
$310.1 million
Net cash provided by operating activities, three months ended March 31, 2026
Fiscal 2027 Adjusted EBITDA guidance
$210–$240 million
Guidance for year ending March 31, 2027
Key Terms
Adjusted EBITDA, Adjusted Free Cash Flow, net debt, interest coverage, +2 more
6 terms
Adjusted EBITDA financial
"Full-Year Adjusted EBITDA Reached a Record $226.7 million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Adjusted Free Cash Flow financial
"adjusted free cash flow of $352.1 million for the three months ended March 31, 2026"
Adjusted free cash flow is the amount of money a company generates from its operations after accounting for essential expenses and investments, like maintaining or upgrading equipment. It shows how much cash is truly available to grow the business, pay debts, or return to shareholders, helping investors see the company's financial health more clearly.
net debt financial
"Net debt (1) | | | | $ | 798,552 | | $ | 771,638"
Net debt is the total amount a company owes after subtracting the cash and assets it has that can be used to pay off that debt. It shows how much debt is truly a burden, helping investors understand if a company is financially healthy or heavily borrowed. Think of it like calculating how much money you owe after using your savings to pay part of it.
interest coverage financial
"our interest coverage over the last twelve months improved to 1.63 times"
Interest coverage is a measure of a company's ability to pay the interest on its debts with its earnings. It shows how comfortably the company can cover interest costs, similar to how many times a person’s income can pay their monthly bills. A higher interest coverage indicates the company is less likely to struggle to meet its interest payments, which can be reassuring for investors.
oversupply position financial
"the global tobacco market has turned to an oversupply position"
accounts receivable securitization programs financial
"sold receivables under the Company's accounts receivable securitization programs"
Earnings Snapshot
Revenue: $2.413 billion · Guidance included
Fiscal year ended March 31, 2026
Revenue
$2.413 billion
-2.8% vs fiscal 2025
Q4 Revenue
$678.2 million
+35.2% vs Q4 2025
Operating income
$162.7 million
up from $153.3 million in 2025
Net income attributable to Pyxus
$14.6 million
slightly below $15.2 million in 2025
Adjusted EBITDA
$226.7 million
up from $208.4 million in 2025
Guidance
For fiscal 2027, Pyxus anticipates sales between $2.3 billion and $2.5 billion and Adjusted EBITDA between $210 million and $240 million.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 4, 2026
(Exact name of Registrant, as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission file number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of principal executive offices, including zip code)
(919 ) 379-4300
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
The information in this report shall not be deemed to be “filed” for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation by reference language contained therein, except as shall be expressly set forth by specific reference in such a filing.
| Item 2.02 | Results of Operations and Financial Condition | ||||
On June 4, 2026, Pyxus International, Inc. issued a press release announcing its operating and financial results for the quarter and fiscal year ended March 31, 2026. The press release is furnished as Exhibit 99.1 hereto.
| Item 9.01 | Financial Statements and Exhibits | ||||
(d) Exhibits
Exhibit No. | Description | |||||||
| 99.1 | Press release dated June 4, 2026 | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 4, 2026
| PYXUS INTERNATIONAL, INC. | ||||||||
| By: | /s/ T. David Singer | |||||||
| T. David Singer | ||||||||
| Senior Vice President – Chief Legal | ||||||||
| Officer and Secretary | ||||||||
Exhibit 99.1
| Pyxus International, Inc. | Tel: | (919) 379-4300 |  | ||||||||||||||
| 6001 Hospitality Court | Fax: | (919) 379-4346 | |||||||||||||||
| Suite 100 | www.pyxus.com | ||||||||||||||||
| Morrisville, NC 27560-2009 | |||||||||||||||||
| USA | |||||||||||||||||
| NEWS RELEASE | Contact: | Tomas Grigera | ||||||||||||||||||||||||
| (919) 379-4300 | ||||||||||||||||||||||||||
Pyxus International, Inc. Reports Strong Fourth Quarter Performance, Concludes Year of Continued Positive Momentum
— Q4 Net Sales up 35.2% Year-over-Year —
— Increased Full-Year Operating Income to $162.7 million and Net Income to $14.6 million —
— Full-Year Adjusted EBITDA Reached a Record $226.7 million —
— Leverage Ratio Improved to 3.52x, a Multi-Year Low —
Morrisville, N.C. – June 4, 2026 – Pyxus International, Inc. (OTCID: PYYX) ("Pyxus," the "Company," "we," or "our"), a global value-added agricultural company, today announced results for its fourth quarter and fiscal year ended March 31, 2026.
Pieter Sikkel, Pyxus' President and Chief Executive Officer, said, "Fiscal 2026 marks another year of outstanding financial and operational results for Pyxus, concluding from a position of strength with exemplary fourth quarter results. Our consistent performance reflects the resilience and adaptability of our global teams, who worked together to navigate the shift to an oversupply market, meeting sustained customer demand. Their strategic execution enabled the achievement of record adjusted EBITDA, strong margins and improved credit metrics, underscoring our ability to deliver our plan in any environment.
"As we enter fiscal year 2027, we are well positioned to manage the dynamic market, leveraging a disciplined operating model and deep customer insights to make demand-led purchasing decisions. We anticipate steady customer demand and sufficient supply, driving favorable outcomes including decreased crop costs and improved working capital, providing an opportunity to further strengthen our business fundamentals as we continue to deliver value to our stakeholders this year and well into the future."
Fourth Quarter and Full-Year Fiscal 2026 Results
Sales and other operating revenues increased $176.5 million, or 35.2%, to $678.2 million for the three months ended March 31, 2026 from $501.7 million for the three months ended March 31, 2025. This increase was a result of higher leaf sales volumes from Africa and North America driven by larger crops and shipment timing.
Sales and other operating revenues decreased $68.3 million, or 2.8%, to $2,413.0 million for the year ended March 31, 2026 from $2,481.3 million for the year ended March 31, 2025. This was a result of a 3.8% decrease in average price per kilo, primarily in Africa, with pricing reflective of the lower costs to purchase the current crop in South America, and lower leaf product revenues driven by a decline in value-added tobacco products sales volumes. The decrease in leaf product revenues was partially offset by volume growth in third-party processing, mainly from Africa and North America.
Gross profit increased $27.2 million, or 40.4%, to $94.4 million for the three months ended March 31, 2026 from $67.2 million for the three months ended March 31, 2025. In addition, gross profit as a percent of sales increased to 13.9% in the current quarter, from 13.4% for the same period a year ago. The improvement in our gross profit and related gross profit percentage is largely due to higher leaf product sales volumes in South America and North America.
Gross profit increased $4.7 million, or 1.4%, to $347.7 million for the year ended March 31, 2026 from $343.0 million for the year ended March 31, 2025, and gross profit as a percent of sales increased to 14.4%, compared to 13.8% in the prior fiscal
1
year. These increases are mainly attributable to higher volumes from third-party processing in Africa and North America and increased leaf product sales volumes in South America.
Selling, general, and administrative expenses as a percent of sales decreased to 6.8% for the year ended March 31, 2026 from 6.9% for the year ended March 31, 2025. Selling, general, and administrative expenses decreased $8.1 million, or 4.7%, to $162.9 million for the year ended March 31, 2026 from $171.0 million for the year ended March 31, 2025, primarily driven by a lower accrual for variable incentive compensation and less equity-based compensation expense, partially offset by increased personnel costs.
The Company’s operating income for the fourth quarter of fiscal 2026 was $43.7 million as compared to $13.7 million in the fourth quarter of fiscal 2025, a direct result of the increase in gross profit over the same period.
Operating income increased 6.1% to $162.7 million for the year ended March 31, 2026, compared to $153.3 million in the prior year due to the increase in gross profit and the decrease in selling, general, and administrative expenses.
Select Balance Sheet and Liquidity Information
Our strong sales and cash collections, including collections from securitized receivables and advances from customers during the fourth quarter, resulted in a $56.1 increase in cash and cash equivalents at March 31, 2026 compared to the prior year-end, and produced cash flow from operations of $310.1 million and adjusted free cash flow of $352.1 million for the three months ended March 31, 2026. While our balance sheet continues to reflect the impact of larger crop purchases primarily in Africa and South America, we are pleased with our strong cash position heading into our peak buying season in the Southern Hemisphere, and with no outstanding borrowings on our $150.0 million ABL at the end of the fiscal year.
As expected, the global tobacco market has turned to an oversupply position, which was driven by higher production in Africa and South America. Our total tobacco inventory at fiscal year end was $786.7 million up from $732.2 million in the prior year due to the timing of shipments and our crop purchases in Africa. The higher tobacco inventory balance is expected to result in more carry-over sales in fiscal year 2027 versus fiscal year 2026. At March 31, 2026, our uncommitted inventory balance was $45.2 million, or approximately 9% of our total processed inventory, which is consistent with a global oversupply environment.
Our continued focus on liquidity improvement enabled us to operate efficiently and capture the necessary volumes to support continued growth in adjusted EBITDA and other key profitability in fiscal year 2026. Our increased profitability metrics, along with continued financial discipline, improved our leverage from 3.70x at March 31, 2025 to 3.52x at March 31, 2026, and our interest coverage over the last twelve months improved to 1.63 times, up from 1.57 times in the previous year.
Fiscal 2027 Guidance
For the fiscal year ending March 31, 2027, Pyxus anticipates sales to be between $2.3 billion and $2.5 billion and adjusted EBITDA to be between $210 million and $240 million.
Financial Results Investor Call
The Company will hold an earnings conference call and webcast on Thursday, June 4, 2026 at 9 a.m. EDT. Investors and analysts interested in participating in the call are invited to dial (646) 769-9200 or (800) 330-6710 and use conference ID 8374629. The webcast can be accessed at http://investors.pyxus.com.
A presentation of fourth quarter and fiscal year ended March 31, 2026 results will be available on the Company's investor relations webpage prior to the call. For those unable to join the live audio webcast, the archived recording will be available on the Company's investor relations webpage shortly after the call.
Any replay, rebroadcast, transcript, or other reproduction of this conference call, other than the replay accessible by calling the number above, has not been authorized by Pyxus and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.
Cautionary Statement Regarding Forward-Looking Statements
Readers are cautioned that the statements contained in this report regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are based on current expectations of future events, may be identified by the use of words such as "guidance", "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," and other words of similar meaning. These statements also may be
2
identified by the fact that they do not relate strictly to historical or current facts. If underlying assumptions prove inaccurate, or if known or unknown risks or uncertainties materialize, actual results could vary materially from those anticipated, estimated, or projected. These risks and uncertainties include those discussed in our Annual Report on Form 10-K for the year ended March 31, 2025, our Quarterly Report on Form 10-Q for the period ended December 31, 2025 and in our other filings with the Securities and Exchange Commission. These risks and uncertainties include: our reliance on a small number of significant customers; continued vertical integration by our customers; global shifts in sourcing customer requirements, including as a result of the imposition of, and changes to, tariffs and other changes in international trade policies; variation in our financial results due to growing conditions, customer indications and other factors; loss of confidence in us by our customers, farmers and other suppliers; migration of suppliers who have historically grown tobacco and from whom we have purchased tobacco toward growing other crops; risks related to our advancement of inputs to tobacco suppliers to be settled upon the suppliers delivering us unprocessed tobacco at the end of the growing season; risks that the tobacco we purchase directly from suppliers will not meet our customers’ quality and quantity requirements; weather and other environmental conditions that can affect the quantity and marketability of our inventory; the impact of increased competition on our earnings; continued high inflation that may adversely affect our profitability and the demand for our leaf tobacco products; international business risks, including unsettled political conditions, uncertainty in the enforcement of legal obligations, including the collection of accounts receivable, fraud risks, expropriation, import and export restrictions, exchange controls, inflationary economies, currency risks, risks related to the restrictions on repatriation of earnings or proceeds from liquidated assets of foreign subsidiaries and impacts of international sanctions on our ability to sell or source tobacco in certain regions; risks and uncertainties related to geopolitical conflicts, including the armed conflicts in the Middle East and disruptions in shipping in that area; risks related to our operations in jurisdictions that pose a high risk of potential violations of the Foreign Corrupt Practices Act; exposure to foreign tax regimes in which the rules are not clear, are not consistently applied and are subject to sudden change; fluctuations in foreign currency exchange and interest rates; disruption, failure or security breaches of our information technology systems and other cybersecurity risks; regulations regarding environmental matters that may substantially increase our costs and expose us to potential liability; changing sustainability regulatory requirements and expectations; exposure to product liability claims, regulatory action, and litigation in the event such products are alleged to have caused injury, harm, or death; risks related to our capital structure, including risks related to our significant debt and our ability to continue to finance our non-U.S. local operations with uncommitted short-term operating credit lines at the local level; our ability to continue to access capital markets to obtain long-term and short-term financing, and our substantial debt which may adversely affect us by limiting future sources of financing, interfering with our ability to pay interest and principal on our indebtedness, and subjecting us to additional risks; potential failure of foreign banks in which our subsidiaries maintain deposits or the failure by such banks to transfer funds or honor withdrawals; the risk that, because our ability to generate cash depends on many factors beyond our control, we may be unable to generate the significant amount of cash required to service our indebtedness; our ability to refinance our current credit facilities at the same availability or at similar or reduced interest rates, including due to volatility and disruption of global credit markets; failure to achieve our stated goals, which may adversely affect our liquidity; developments with respect to our liquidity needs and sources of liquidity; failure by counterparties to derivative transactions to perform their obligations; certain shareholders have the ability to exercise controlling influence on various corporate matters; reductions in demand for cigarettes and other consumer tobacco products; legislative and regulatory initiatives that may reduce consumption of consumer tobacco products and demand for our services and increase regulatory burdens on us or our customers; government actions that significantly affect the sourcing of tobacco, including governmental actions to identify and assess crop diversification initiatives and alternatives to leaf tobacco growing in countries whose economies depend upon tobacco production; and governmental investigations into our business activities, including, but not limited to, leaf tobacco industry buying and other payment practices. We do not undertake to update any forward-looking statements that we may make from time to time except to the extent required by law.
Non-GAAP Financial Information
This press release contains financial measures that have not been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). They include EBITDA, Adjusted EBITDA, adjusted free cash flow, and net debt. Tables showing the reconciliation of historical non-GAAP financial measures are attached to the release. The range of adjusted EBITDA anticipated for the fiscal year ending March 31, 2027 is calculated in a manner consistent with the presentation of adjusted EBITDA in the attached tables. Because of the forward-looking nature of the estimated range of adjusted EBITDA, it is impractical to present a quantitative reconciliation of such measure to a comparable GAAP measure, and accordingly no such GAAP measure is being presented.
About Pyxus International, Inc.
Pyxus International, Inc. is a global agricultural company with more than 150 years of experience delivering value-added products and services to businesses and customers. Driven by a united purpose—to transform people’s lives, so that together we can grow a better world—Pyxus, its subsidiaries and affiliates, are trusted providers of responsibly sourced, independently verified, sustainable and traceable products and ingredients. For more information, visit www.pyxus.com.
3
Consolidated Statements of Operations
| Three Months Ended March 31, | ||||||||
| (in thousands, except per share data) | 2026 | 2025 | ||||||
| Sales and other operating revenues | $ | 678,177 | $ | 501,715 | ||||
| Cost of goods and services sold | 583,805 | 434,499 | ||||||
| Gross profit | 94,372 | 67,216 | ||||||
| Selling, general, and administrative expenses | 44,139 | 44,948 | ||||||
| Other expense, net | 5,320 | 6,724 | ||||||
| Restructuring and asset impairment charges | 1,227 | 1,843 | ||||||
Operating income | 43,686 | 13,701 | ||||||
| Loss on pension settlement | (90) | — | ||||||
| Interest expense, net | 30,098 | 26,106 | ||||||
| Income (loss) before income taxes and other items | 13,498 | (12,405) | ||||||
| Income tax expense (benefit) | 4,515 | (7,195) | ||||||
| Income from unconsolidated affiliates, net | 5,677 | 654 | ||||||
| Net income (loss) | 14,660 | (4,556) | ||||||
| Net income attributable to noncontrolling interests | 290 | 591 | ||||||
| Net income (loss) attributable to Pyxus International, Inc. | $ | 14,370 | $ | (5,147) | ||||
| Earnings (loss) per share: | ||||||||
| Basic | $ | 0.56 | $ | (0.20) | ||||
| Diluted | $ | 0.55 | $ | (0.20) | ||||
4
Consolidated Statements of Operations
| Years Ended March 31, | |||||||||||
| (in thousands, except per share data) | 2026 | 2025 | 2024 | ||||||||
| Sales and other operating revenues | $ | 2,413,000 | $ | 2,481,260 | $ | 2,032,559 | |||||
| Cost of goods and services sold | 2,065,321 | 2,138,276 | 1,720,224 | ||||||||
| Gross profit | 347,679 | 342,984 | 312,335 | ||||||||
| Selling, general, and administrative expenses | 162,934 | 170,998 | 160,910 | ||||||||
| Other expense, net | 19,193 | 16,410 | 9,439 | ||||||||
| Restructuring and asset impairment charges | 2,852 | 2,259 | 4,799 | ||||||||
| Operating income | 162,700 | 153,317 | 137,187 | ||||||||
| Gain on debt retirement | — | 8,178 | 15,914 | ||||||||
| Gain (loss) on pension settlement | 283 | — | (12,008) | ||||||||
| Interest expense, net | 134,353 | 128,041 | 125,620 | ||||||||
| Income before income taxes and other items | 28,630 | 33,454 | 15,473 | ||||||||
| Income tax expense | 30,344 | 25,053 | 27,281 | ||||||||
| Income from unconsolidated affiliates, net | 17,371 | 8,132 | 14,992 | ||||||||
| Net income | 15,657 | 16,533 | 3,184 | ||||||||
| Net income attributable to noncontrolling interests | 1,088 | 1,367 | 521 | ||||||||
| Net income attributable to Pyxus International, Inc. | $ | 14,569 | $ | 15,166 | $ | 2,663 | |||||
| Earnings per share: | |||||||||||
| Basic | $ | 0.56 | $ | 0.59 | $ | 0.11 | |||||
| Diluted | $ | 0.56 | $ | 0.59 | $ | 0.11 | |||||
5
Consolidated Balance Sheets
| (in thousands) | March 31, 2026 | March 31, 2025 | ||||||
| Assets | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 134,337 | $ | 78,254 | ||||
| Restricted cash | 3,316 | 7,290 | ||||||
| Trade receivables, net | 239,456 | 189,239 | ||||||
| Other receivables | 25,451 | 15,040 | ||||||
| Inventories, net | 817,950 | 761,951 | ||||||
| Advances to suppliers, net | 36,337 | 30,745 | ||||||
| Recoverable income taxes | 2,886 | 6,616 | ||||||
| Prepaid expenses | 49,000 | 47,151 | ||||||
| Other current assets | 21,751 | 21,874 | ||||||
| Total current assets | 1,330,484 | 1,158,160 | ||||||
| Investments in unconsolidated affiliates | 105,863 | 96,928 | ||||||
| Intangible assets, net | 24,076 | 28,507 | ||||||
| Deferred income taxes, net | 14,507 | 13,567 | ||||||
| Long-term recoverable income taxes | 9,467 | 5,669 | ||||||
| Other noncurrent assets | 35,424 | 33,094 | ||||||
| Right-of-use assets | 31,717 | 29,742 | ||||||
| Property, plant, and equipment, net | 143,154 | 138,176 | ||||||
| Total assets | $ | 1,694,692 | $ | 1,503,843 | ||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities | ||||||||
| Notes payable | $ | 477,132 | $ | 395,030 | ||||
| Accounts payable | 146,828 | 132,871 | ||||||
| Advances from customers | 174,995 | 135,607 | ||||||
| Accrued expenses and other current liabilities | 114,760 | 90,912 | ||||||
| Income taxes payable | 9,145 | 11,001 | ||||||
| Operating leases payable | 9,915 | 8,514 | ||||||
| Current portion of long-term debt | — | 12 | ||||||
| Total current liabilities | 932,775 | 773,947 | ||||||
| Long-term taxes payable | 4,112 | 5,187 | ||||||
| Long-term debt | 455,757 | 454,850 | ||||||
| Deferred income taxes | 11,961 | 8,818 | ||||||
| Liability for unrecognized tax benefits | 28,074 | 18,635 | ||||||
| Long-term leases | 21,020 | 19,584 | ||||||
| Pension, postretirement, and other long-term liabilities | 59,886 | 57,052 | ||||||
| Total liabilities | 1,513,585 | 1,338,073 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ equity | ||||||||
Common stock—no par value: | ||||||||
Authorized shares (250,000 for all periods) | ||||||||
Issued and outstanding shares (24,608 for all periods) | 393,921 | 392,899 | ||||||
| Retained deficit | (225,556) | (240,125) | ||||||
| Accumulated other comprehensive income | 6,123 | 7,315 | ||||||
| Total stockholders’ equity of Pyxus International, Inc. | 174,488 | 160,089 | ||||||
| Noncontrolling interests | 6,619 | 5,681 | ||||||
| Total stockholders’ equity | 181,107 | 165,770 | ||||||
| Total liabilities and stockholders’ equity | $ | 1,694,692 | $ | 1,503,843 | ||||
6
Segment Results
Years Ended March 31, 2026 and 2025
| Years Ended March 31, | Change | |||||||||||||
| (in millions, except per kilo amounts) | 2026 | 2025 | $ | % | ||||||||||
| Leaf: | ||||||||||||||
| Product revenues | $ | 2,235.8 | $ | 2,335.1 | (99.3) | (4.3) | ||||||||
| Tobacco costs | 1,808.0 | 1,905.5 | (97.5) | (5.1) | ||||||||||
| Transportation, storage, and other period costs | 115.8 | 108.5 | 7.3 | 6.7 | ||||||||||
| Total product cost of goods sold | 1,923.8 | 2,014.0 | (90.2) | (4.5) | ||||||||||
| Product gross profit | 312.0 | 321.1 | (9.1) | (2.8) | ||||||||||
| Product gross profit as a percent of sales | 14.0 | % | 13.8 | % | ||||||||||
| Kilos sold | 381.7 | 383.4 | (1.7) | (0.4) | ||||||||||
| Average price per kilo | $ | 5.86 | $ | 6.09 | (0.23) | (3.8) | ||||||||
| Average cost per kilo | 5.04 | 5.25 | (0.21) | (4.0) | ||||||||||
| Average gross profit per kilo | 0.82 | 0.84 | (0.02) | (2.4) | ||||||||||
| Processing and other revenues | $ | 169.3 | $ | 135.9 | 33.4 | 24.6 | ||||||||
| Processing and other costs of services sold | 135.3 | 111.8 | 23.5 | 21.0 | ||||||||||
| Processing and other gross profit | 34.0 | 24.1 | 9.9 | 41.1 | ||||||||||
| Processing and other gross profit as a percent of sales | 20.1 | % | 17.7 | % | ||||||||||
| All Other: | ||||||||||||||
| Sales and other operating revenues | $ | 7.9 | $ | 10.3 | (2.4) | (23.3) | ||||||||
| Cost of goods and services sold | 6.2 | 12.5 | (6.3) | (50.4) | ||||||||||
| Gross profit (loss) | 1.7 | (2.2) | 3.9 | 177.3 | ||||||||||
| Gross profit (loss) as a percent of sales | 21.5 | % | (21.4) | % | ||||||||||
7
Reconciliation of Certain Non-GAAP Financials Measures (1) (Unaudited)
| Three Months Ended March 31, | Fiscal Years Ended March 31, | ||||||||||||||||
| (in thousands) | 2026 | 2025 | 2026 | 2025 | 2024 | ||||||||||||
| Net income (loss) attributable to Pyxus International, Inc. | $ | 14,370 | $ | (5,147) | $ | 14,569 | $ | 15,166 | $ | 2,663 | |||||||
| Plus: Interest expense | 31,760 | 27,426 | 138,749 | 133,108 | 132,174 | ||||||||||||
| Plus: Income tax expense (benefit) | 4,515 | (7,195) | 30,344 | 25,053 | 27,281 | ||||||||||||
| Plus: Depreciation and amortization expense | 5,246 | 5,296 | 20,893 | 20,334 | 19,250 | ||||||||||||
EBITDA (1) | 55,891 | 20,380 | 204,555 | 193,661 | 181,368 | ||||||||||||
Plus: (Recoveries) reserves for doubtful customer receivables | (357) | (580) | (648) | 103 | 640 | ||||||||||||
| Plus: Other expense, net | 5,320 | 6,724 | 19,193 | 16,410 | 9,439 | ||||||||||||
Plus: Noncash equity-based compensation | 257 | 211 | 1,022 | 4,110 | — | ||||||||||||
Plus: Restructuring and asset impairment charges (2) | 1,227 | 1,843 | 2,852 | 2,259 | 4,799 | ||||||||||||
Less: Gain on debt retirement | — | — | — | 8,178 | 15,914 | ||||||||||||
| Plus: Debt restructuring | — | — | — | — | 330 | ||||||||||||
Plus: Loss (gain) on pension settlement (3) | 90 | — | (283) | — | 12,008 | ||||||||||||
Plus: Other adjustments (4) | (10) | 28 | (26) | 45 | 1,247 | ||||||||||||
Adjusted EBITDA (1) | $ | 62,418 | $ | 28,606 | $ | 226,665 | $ | 208,410 | $ | 193,917 | |||||||
| Total debt | $ | 932,889 | $ | 849,892 | $ | 1,017,340 | |||||||||||
| Less: Cash | 134,337 | 78,254 | 92,569 | ||||||||||||||
Net debt (1) | $ | 798,552 | $ | 771,638 | $ | 924,771 | |||||||||||
Net debt / Adjusted EBITDA (1) | 3.52x | 3.70x | 4.77x | ||||||||||||||
Adjusted EBITDA (1) | $ | 226,665 | $ | 208,410 | $ | 193,917 | |||||||||||
| Interest expense | 138,749 | 133,108 | 132,174 | ||||||||||||||
| Interest coverage | 1.63x | 1.57x | 1.47x | ||||||||||||||
| Net cash provided by (used in) operating activities | $ | 310,121 | $ | 158,302 | $ | (208,451) | $ | (13,386) | $ | (214,970) | |||||||
| Capital expenditures | (6,271) | (7,909) | (22,051) | (23,028) | (21,043) | ||||||||||||
Collections from beneficial interests in securitized trade receivables (5) | 48,200 | 45,488 | 200,684 | 188,312 | 175,911 | ||||||||||||
Adjusted Free Cash Flow (1) | $ | 352,050 | $ | 195,881 | $ | (29,818) | $ | 151,898 | $ | (60,102) | |||||||
8
(1)Earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"), Adjusted Free Cash Flow, and Net Debt are not measures of results of operations, cash flows from operations or indebtedness under generally accepted accounting principles in the United States ("U.S. GAAP") and should not be considered as an alternative to other U.S. GAAP measurements. We have presented EBITDA, Adjusted EBITDA, Adjusted Free Cash Flow, and Net Debt to adjust for the items identified above because we believe that it would be helpful to the readers of our financial information to understand the impact of these items on our reported amounts. This presentation enables readers to better compare our results to similar companies that may not incur the impact of various items identified above. Management acknowledges that there are many items that impact a company's reported results or operating cash flows and these lists are not intended to present all items that may have impacted these items. EBITDA, Adjusted EBITDA, Adjusted Free Cash Flow, Net Debt, and any ratios calculated based on these measures are not necessarily comparable to similarly-titled measures used by other companies or appearing in our debt obligations or agreements. EBITDA, Adjusted EBITDA and Adjusted Free Cash Flow as presented may not equal column or row totals due to rounding.
(2)Amounts incurred during the fiscal year ended March 31, 2024 included employee separation charges primarily related to changes in the corporate organizational structure and the continued restructuring of certain leaf operations and asset impairment charges primarily related to continued restructuring of certain non-leaf agriculture operations.
(3)During the fiscal year ended March 31, 2024, the Company terminated its U.K. Pension Plan. The Company recorded a noncash pension settlement charge which included the disposition of the U.K. Pension Plan assets and reclassification of unrecognized net pension losses within accumulated other comprehensive income (loss) into the Company's consolidated statements of operations.
(4)Includes other individually insignificant adjustments that are not reflective of the Company's ongoing operations.
(5)Represents cash receipts from the beneficial interest on sold receivables under the Company's accounts receivable securitization programs and are classified as investing activities within the consolidated statements of cash flows.
9
FAQ
How did Pyxus International (PYYX) perform in Q4 of fiscal 2026?
Pyxus delivered a strong Q4 2026, with net sales rising 35.2% year-over-year to $678.2 million and gross profit increasing to $94.4 million. Operating income jumped to $43.7 million, supported by higher leaf sales volumes from Africa and North America and improved margins.
What were Pyxus International’s full-year 2026 revenue and profit results?
For fiscal 2026, Pyxus reported sales of $2.413 billion, down 2.8% from 2025 as lower average pricing offset volume growth. Operating income increased to $162.7 million, while net income attributable to Pyxus reached $14.6 million, or $0.56 per diluted share, reflecting better profitability.
What record profitability metrics did Pyxus International (PYYX) achieve in fiscal 2026?
Pyxus achieved record full-year Adjusted EBITDA of $226.7 million in fiscal 2026, up from $208.4 million in 2025. The company also improved gross profit to $347.7 million and enhanced key credit metrics, including lower net leverage and higher interest coverage versus the prior year.
How did Pyxus International’s leverage and liquidity change in fiscal 2026?
Pyxus reduced its net debt/Adjusted EBITDA ratio to 3.52x at March 31, 2026, from 3.70x a year earlier. Cash and cash equivalents increased to $134.3 million, and Q4 operating cash flow reached $310.1 million, supporting a stronger liquidity position heading into the next fiscal year.
What is Pyxus International’s fiscal 2027 guidance for sales and Adjusted EBITDA?
For the year ending March 31, 2027, Pyxus anticipates sales between $2.3 billion and $2.5 billion and Adjusted EBITDA between $210 million and $240 million. This guidance reflects expectations for steady demand amid a global tobacco oversupply and continued disciplined operations.
How is the global tobacco oversupply affecting Pyxus International (PYYX)?
The global tobacco market has shifted to an oversupply position, driven by higher production in Africa and South America. Pyxus ended fiscal 2026 with $786.7 million of tobacco inventory and $45.2 million of uncommitted inventory, expecting more carry-over sales into fiscal 2027 under this environment.
What were Pyxus International’s key non-GAAP metrics like Adjusted Free Cash Flow?
In Q4 2026, Pyxus generated Adjusted Free Cash Flow of $352.1 million and full-year Adjusted EBITDA of $226.7 million. These non-GAAP measures, alongside net debt of $798.6 million and improved interest coverage of 1.63x, highlight stronger cash generation and credit metrics versus prior years.